CCM
MDCO

Credo Capital Management’s Medicines Co MDCO Stock Holding History

Credo Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$28K Buy
+724
New +$25.9K 0.12% 102

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAC
Smith Affiliated Capital New York $86.5B AUM 5.91% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Credo Capital Management's MDCO Position: Q4 2013 in Review

Credo Capital Management opened a new position in Medicines Co (MDCO) in Q4 2013: 724 shares worth $28K. The stake represents 0.12% of the portfolio and ranks #102 among its holdings.

182 funds tracked by Wall St. Rank hold MDCO as of Q4 2013.

  • Credo Capital Management held 724 shares of Medicines Co worth $28K as of Q4 2013.
  • Medicines Co was a new Credo Capital Management position in Q4 2013.
  • Medicines Co made up 0.12% of Credo Capital Management's portfolio in Q4 2013, its #102 holding.
  • 182 funds tracked by Wall St. Rank held Medicines Co as of Q4 2013.

Based on Credo Capital Management's 13F filing for Q4 2013, filed 24 Jan 2014.